Resource Guide: Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Recommended deep-dive

Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.

MedlinePlus — Trusted Health Information

Reference: MedlinePlus — Trusted Health Information

Authoritative source for clinical, regulatory, and public-health background reading.